- UroToday Home
- Urologic Oncology
The Latest Renal Cancer Research
Recent Abstracts
-
Efficacy and Safety of Nivolumab With Ipilimumab in Elderly Patients With Advanced Renal Cell Carcinoma.Renal CancerNovember 1, 2024
-
AI predictive modeling of survival outcomes for renal cancer patients undergoing targeted therapy.Renal CancerNovember 1, 2024
-
Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older.Renal CancerOctober 31, 2024
-
Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to Power.Renal CancerOctober 31, 2024
-
Factors associated with surgical refusal and non-surgical candidacy in stage 1 kidney cancer: a National Cancer Database (NCDB) analysis.Renal CancerOctober 30, 2024
-
Impact of a kidney-adjusted ERAS® protocol on postoperative outcomes in patients undergoing partial nephrectomy.Renal CancerOctober 29, 2024
-
Meta-analysis and systematic review of factors predicting conversion to radical nephrectomy following robotic-assisted partial nephrectomy in renal cancer patients.Renal CancerOctober 29, 2024
-
T1a renal cancer cryoablation - first experiences in Poland.Renal CancerOctober 28, 2024
-
Aggressiveness classification of clear cell renal cell carcinoma using registration-independent radiology-pathology correlation learning.Renal CancerOctober 28, 2024
-
Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients.Renal CancerOctober 25, 2024
Beyond the Abstracts
-
Differences in Mutations Across Tumour Sizes in Clear-Cell Renal Cell Carcinoma - Beyond the AbstractRenal CancerOctober 21, 2024
-
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1) - Beyond the AbstractRenal CancerOctober 15, 2024
-
Diagnostic Accuracy and Safety of Renal Tumour Biopsy in Patients with Small Renal Masses and Its Impact on Treatment Decisions - Beyond the AbstractRenal CancerOctober 14, 2024
-
A Genetic Basis for Sex Differences in Xp11 Translocation Renal Cell Carcinoma - Beyond the AbstractRenal CancerSeptember 11, 2024
-
International Multicenter Real-World REGistry for Patients with Metastatic renAL Cell Carcinoma - Meet-URO 33 Study (REGAL Study) - Beyond the AbstractRenal CancerSeptember 6, 2024
-
Treatment-Free Survival and Partitioned Survival Analysis of Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab plus Ipilimumab Versus Sunitinib: 5-Year Update of CheckMate 214 - Beyond the AbstractRenal CancerAugust 29, 2024
-
Prognostic Significance of Inflammatory Markers in Patients with Advanced Renal Cell Carcinoma Receiving Nivolumab plus Ipilimumab - Beyond the AbstractRenal CancerAugust 23, 2024
-
Long-Term Responders to Nivolumab in Previously Treated Advanced Renal Cell Carcinoma: A Sub-Analysis of Meet-URO15 Study - Beyond the AbstractRenal CancerAugust 22, 2024
-
The Current Application and Future Potential of Artificial Intelligence in Renal Cancer - Beyond the AbstractRenal CancerAugust 8, 2024
-
Prognostic Significance of Absolute Lymphocyte Count in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Combination Immunotherapies - Beyond the AbstractRenal CancerAugust 6, 2024